文献速递免疫规划传染病防控与疫情报告

10价肺炎球菌疫苗引入前肺炎链球菌携带率及血清型分布:2014年乌干达西南部基于人群的横断面研究

Carriage prevalence and serotype distribution of Streptococcus pneumoniae prior to 10-valent pneumococcal vaccine introduction: A population-based cross-sectional study in South Western Uganda, 2014.
PubMed 文献 · Vaccine · 2017-08-04

2014年1月至3月在乌干达西南部Sheema北分区开展两阶段整群、年龄分层、社区横断面研究,按世界卫生组织指南采集鼻咽拭子。2岁以下儿童肺炎球菌携带率为77%(n=387),≥15岁为8.5%(n=325),差异有统计学意义(卡方检验 P<0.001)。携带的肺炎球菌血清型中含PCV10血清型的比例在各年龄组均低于40%,≥15岁组仅4.4%(n=22)。

要点

  • 2岁以下儿童肺炎球菌携带率77%,显著高于≥15岁组的8.5%(P<0.001)。
  • 2岁以下儿童中6A、6B、14、15B、19F和23F血清型占所有携带者的一半。
  • 各年龄组携带PCV10血清型比例均低于40%,≥15岁组仅4.4%。

核心结论

  • Sheema地区各年龄组携带的肺炎球菌中含PCV10血清型的比例均较低(<40%),尤其是≥15岁人群(<5%)。
  • PCV10引入可能影响儿童和较大年龄人群的传播,但不太可能大幅改变≥15岁人群的肺炎球菌鼻咽生态。

研究设计与样本

  • 2014年1月至3月在乌干达西南部Sheema北分区开展两阶段整群、年龄分层、社区横断面研究。
  • 每位参与者采集一份鼻咽拭子,按世界卫生组织指南进行分析。

主要发现

  • 2岁以下儿童任何血清型肺炎球菌鼻咽携带率为77%(n=387),≥15岁人群为8.5%(n=325),卡方检验 P<0.001。
  • 623份阳性培养物中,610株(97.9%)鉴定出49种血清型,13株(2.1%)不可分型。
  • 2岁以下儿童中,血清型6A、6B、14、15B、19F和23F占所有携带者的一半。
  • PCV10血清型携带率:<2岁组29.4%(n=387),2-4岁组23.4%(n=217),5-14岁组11.4%(n=417),≥15岁组0.4%(n=325)。
  • 携带的肺炎球菌中含PCV10血清型的比例:<2岁携带者38.1%(n=291),2-4岁携带者32.8%(n=154),5-14岁携带者29.4%(n=156),≥15岁携带者4.4%(n=22)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Information on Streptococcus pneumoniae nasopharyngeal (NP) carriage before the pneumococcal conjugate vaccine (PCV) introduction is essential to monitor impact. The 10-valent PCV (PCV10) was officially introduced throughout Ugandan national childhood immunization programs in 2013 and rolled-out countrywide during 2014. We aimed to measure the age-specific Streptococcus pneumoniae carriage and serotype distribution across all population age groups in the pre-PCV10 era in South Western Uganda. METHODS: We conducted a two-stage cluster, age-stratified, cross-sectional community-based study in Sheema North sub-district between January and March 2014. One NP swab was collected and analyzed for each participant in accordance with World Health Organization guidelines. RESULTS: NP carriage of any pneumococcal serotype was higher among children <2years old (77%; n=387) than among participants aged ≥15years (8.5%; n=325) (chi2 p<0.001). Of the 623 positive cultures, we identified 49 serotypes among 610 (97.9%) isolates; thirteen (2.1%) isolates were non-typeable. Among <2years old, serotypes 6A, 6B, 14, 15B, 19F and 23F accounted for half of all carriers. Carriage prevalence with PCV10 serotypes was 29.4% among individuals aged <2years (n=387), 23.4% in children aged 2-4years (n=217), 11.4% in 5-14years (n=417), and 0.4% among individuals ≥15years of age (n=325). The proportion of carried pneumococci serotypes contained in PCV10 was 38.1% (n=291), 32.8% (n=154), 29.4% (n=156), and 4.4% (n=22) among carriers aged <2years, 2-4years, 5-14years and ≥15years, respectively. DISCUSSION: In Sheema district, the proportion of PCV10 serotypes was low (<40%), across all age groups, especially among individuals aged 15years or older (<5%). PCV10 introduction is likely to impact transmission among children and to older individuals, but less likely to substantially modify pneumococcal NP ecology among individuals aged 15years or older.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Nackers F, Cohuet S, le Polain de Waroux O, et al. Carriage prevalence and serotype distribution of Streptococcus pneumoniae prior to 10-valent pneumococcal vaccine introduction: A population-based cross-sectional study in South Western Uganda, 2014. Vaccine. 2017. PMID: 28784282. doi:10.1016/j.vaccine.2017.07.081

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。